Categories: News

CDR-Life to Present at the American Society of Hematology’s 2021 Annual Meeting

ZÜRICH, Switzerland, Nov. 08, 2021 (GLOBE NEWSWIRE) — CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of highly tumor-specific immuno-oncology therapeutics based on its proprietary antibody-based T cell engager technology, today announced that preclinical data from the Company’s CDR101 candidate will be presented in a poster at the 63rd Annual American Society of Hematology (ASH) meeting being held in Atlanta, Georgia from December 11-14, 2021.

Details for the poster presentation are as follows:

Abstract Number: 1583
Poster Title: Preclinical Assessment of CDR101 – a BCMAxCD3xPD-L1 Trispecific Antibody with Superior Anti-Tumor Efficacy
Session Number & Name: 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster I Hematology Disease Topics & Pathways: Biological, Translational Research, Bispecific Antibody Therapy, Plasma Cell Disorders, Checkpoint Inhibitor, Diseases, Therapies, Lymphoid Malignancies
Session Date: Saturday, December 11, 2021
Session Time: 5:30 PM – 7:30 PM
Presenter: Melissa Vrohlings, Immunology Expert, CDR-Life

About CDR-Life Inc.        
CDR-Life is a biotherapeutics company developing novel therapies harnessing the power of the immune system. Using a proprietary antibody platform that targets intracellular tumor antigens presented on the major histocompatibility complex (MHC) with high potency and specificity, the company is advancing a portfolio of tumor-targeted T cell engagers for the treatment of high need solid tumor malignancies. CDR-Life is led by former biologics inventors, pharmaceutical drug developers and company builders, and has an existing collaboration and licensing agreement with Boehringer Ingelheim for a novel antibody fragment therapy to treat geographic atrophy. For more information, please visit www.cdr-life.com.        

Contacts:
Björn Peters, CBO                                        
CDR-Life Inc.                                                 
Phone: +41 44 515 98 98                                
bjoern.peters@cdr-life.com

Argot Partners
CDR-Life@argotpartners.com
Phone: +1-212-600-1902

Staff

Recent Posts

The Doctor and The Athlete: Powerhouse Duo Disrupts Functional Beverage Market with Science-Backed “Happiness”

TAMPA, Fla., Feb. 2, 2026 /PRNewswire/ -- Happy Panda announces its official market launch with a…

5 hours ago

FUGO Precision 3D to Debut Revolutionary Centrifugal 3D Printing Technology with Live Demonstrations at LMT LAB DAY Chicago 2026

GARDENA, Calif., Feb. 2, 2026 /PRNewswire/ -- FUGO Precision 3D, developer of the world's first all-in-one…

5 hours ago

The Micro-Mechanics of Modern Oral Care

OXNARD, CA / ACCESS Newswire / February 2, 2026 / Quality Dental Services functions as…

8 hours ago

Dr. Shahrooz Yazdani Launches $6M Dental Practice Seminar Series to Help Owners Break Free from Burnout

Seminar offers step-by-step blueprint to grow your clinic, build passive income, and regain personal timeOTTAWA,…

11 hours ago

New Aura and UNC-Chapel Hill Study Finds One in Three Kids Have Accessed GenAI Apps

BOSTON, Feb. 2, 2026 /PRNewswire/ -- Aura, a leading AI-powered online safety platform for families,…

11 hours ago

‘Breathable’ Launches to Bring Hope and Humanity Back to Mental Health Care

New online network makes it simple, affordable and stigma-free to connect with licensed therapistsDETROIT, Feb.…

11 hours ago